Stem cell therapy for cornea repair represents a groundbreaking advancement in the field of ocular medicine, offering new hope for patients suffering from corneal injuries previously deemed untreatable.At the forefront of this innovation is the cultivated autologous limbal epithelial cell (CALEC) procedure, which utilizes a patient’s own stem cells to restore the corneal surface effectively.